AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Dermata Therapeutics, Inc. Director's Dealing 2021

Aug 13, 2021

35467_dirs_2021-08-12_d1347826-a234-4f80-9f45-2acf45af9b99.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Dermata Therapeutics, Inc. (DRMA)
CIK: 0001853816
Period of Report: 2021-08-12

Reporting Person: Scott Kathleen D. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2439	Indirect

Footnotes

F1: Shares reported reflect the 1 for 20.5 stock split effected July 1, 2021.